Age-Related Macular Degeneration (ARMD)

Medical content revised by - Last revision 05/12/2018
Age-Related Macular Degeneration (ARMD)

Age-related macular degeneration or ARMD is a disease that affects the central area of the retina,  the macula. As its name suggests, it is a degenerative disease that progresses with age.


What is age-related macular degeneration?

Age-related macular degeneration affects the central area of the retina, the macula, and causes central vision problems, difficulty recognizing faces and reading, etc. Genetic factors and unhealthy habits (poor diet, smoking, lack of exercise) influence the appearance and progression of the illness.


What types of ARMD exist?

We currently classify ARMD into two main types:

  • Dry ARMD (atrophic ARMD to give it its scientific name) in which the tissue of the macular area atrophies and thins. In some cases dry or atrophic ARMD can develop into wet or exudative ARMD.
  • Wet or exudative ARMD, in which there is a thickening of the macular tissue due to swelling or the appearance of neovessels (abnormal vessels or small varicose veins that grow under the retina in the macular area and can cause bleeding, swelling and for liquid to gather and an increase in the thickness of the zone). In advanced stages of wet ARMD, atrophied tissue may also appear in the macular area.
  • There are other less common types of ARMD (known as rare forms of ARMD).

What are the causes? Can it be prevented?

  • GENETIC FACTORS

Many patients are familiar with ARMD because they have a family history of the condition. They often have relatives that went blind later in life or gradually lost their vision.

Others meanwhile have not heard of the illness and are unaware of anyone in their family who has suffered from it. This is because there are less aggressive forms of ARMD or perhaps they did not have contact with sufferers of the disease in their family.

  • SMOKING

There are also other factors involved in ARMD, such as smoking, which has been scientifically proven to accelerate the progression of ARMD.

  • POOR DIET

There are also nutritional factors. Following a Mediterranean diet slows down ARMD progression.

  • DISEASES THAT AFFECT RETINAL BLOOD VESSELS

The diseases that cause alterations in retinal blood vessels, as well as the irrigation and oxygenation of the retina, such as arterial hypertension, diabetes, cholesterol or high level of triglycerides may also accelerate ARMD progression. Therefore, it is important that patients suffering from ARMD have regular analysis and examinations with their family doctor in order to diagnose in time and be able to control these diseases, thus avoiding any worsening of their retinal state.

  • ULTRAVIOLET RAYS

Other less studied factors are the incidence of ultraviolet rays, which may speed up ARMD progression.

  • LACK OF EXERCISE OR UNHEALTHY HABITS

Doing exercise and having a healthy lifestyle in general can help slow down the progression of the illness.


What are its symptoms? How can they be diagnosed?

ARMD is an illness that often causes symptoms in patients as it affects the central part of the retina, the macular area, which is responsible for central vision. Therefore, patients with ARMD usually complain about central vision problems, such as problems reading, writing, recognizing people’s faces… They may also experience blurred central vision, objects may appear different sizes in each eye, colours may appear different, vision may be distorted (straight lines appear curved)…

Early stages of ARMD may not have any sym,ptoms, and our ophthalmologists diagnose them them  in a routine check-up by observing the patient’s eye fundus, where macular abnormalities can be seen. Other tests may then be requested in order to determine what stage the disease is at and follow its evolution.

Patients may lose some vision in one eye without realizing it. That’s why it is important to analyse vision in each eye separately. This can be done by alternatively covering one eye and then the other (occlusion). Ophthalmologists recommend that patients affected by ARMD perform a simple vision test (known as Amsler test) at home so as to detect changes to or worsening of central vision as early as possible.


How is it diagnosed? Are tests required? What do they involve?

ARMD is diagnosed by ophthalmologists by examining the ocular fundus and carrying out a complete exam on the patient if macular abnormalities are detected.

Diagnostic tests are carried out (to detect macular abnormalities, evolution of the disease, the response to treatments prescribed…) and functional tests (analysing the patient’s vision) which may involve:

  • tests to determine the patient’s vision: measuring near and distance visual acuity, Amsler test, campimetry or visual field (which analyses the degree to which central vision is affected);
  • macular scanner: OCT (Optical Coherence Tomography)
  • contrast tests, such as fluorescein and indocyanine green angiography
  • In specific cases, tests for contrast, colour vision, electrophysiology etc can also be requested.

Is there a cure? How can it be treated?

There is no cure for ARMD, but nowadays there are treatments which can slow it down, especially in the case of dry ARMD.

  • WET ARMD

Wet ARMD is normally more aggressive and develops more quickly than dry ARMD.

We have treatments that are drugs that we can inject into the eye and thus slow down the progress of wet ARMD.

Patients undergoing treatment for ARMD with injections will need to attend many visits and check-ups because the drugs we currently use have a duration of a few weeks. Patients will therefore need to come to several check-ups and have various tests.

Although some patients may stabilise, that is not to say that their condition will remain stable. ARMD is a progressive disease and at any moment patients may experience a new bout and require treatment again.

Intravitreal injections are a procedure which does not hurt because the eye is anaesthetised before the drug is injected. This anaesthesia can be carried out using eye drops (topical anaesthesia), or injecting anaesthetic into the zone where the intravitreal injection will be administered (subconjunctival anaesthesia). This is a treatment that is carried out in just a few minutes, on an outpatient basis, and does not require hospital admission. It is important that the patient collaborates and follows the instructions given.

In the case of patients who do not collaborate (for example those with Alzheimer) injections may be administered under sedation.

  • DRY ARMD

There is currently no cure for DRY ARMD,  or drugs that we can inject into the eye to slow down its evolution (as occurs with wet ARMD).

Nutritional supplements may be prescribed, especially during the early stages of wet ARMD, as multiple studies show this may slow down the evolution of the disease.

ARMD is a well-researched disease, as it is the first cause of blindness in elderly patients. This has awaken a great level of interest in finding a remedial treatment or better treatments to stop the disease. There are several ongoing clinical studies that may lead in a few years to better and more efficient treatments that the ones currently available.

In the future, we hope for medicines that last longer and reduce the patient’s burden of tests and visits, which usually makes for a hard situation, as patients affected by ARMD usually require the help of their relatives.


How to prevent ARMD?

The onset of the disease may be delayed and its evolution may be slowed down by eating a healthy diet, not smoking and doing a test once a year to rule out diseases that affect the retina, such as diabetes, high cholesterol, and high triglycerides, watching blood pressure etc. If any of these diseases are present, it is important to carry out the necessary tests. Moreover, some studies have shown that taking nutritional supplements can slow down the progression of dry or atrophying ARMD.

Many of the patients affected by ARMD have a family history of the disease, as it is a condition that may be hereditary. Therefore, some people who have met relatives suffering from this disease, come to undergo routine tests in order to rule out the disease.

Some patients are affected by aggressive ARMD forms that progress very quickly. Despite the current treatments and advices, sometimes the fast vision loss cannot be stopped in these patients. Therefore, it is important to diagnose the disease in early stages and undergo routine tests regularly when the patient has a family history of the disease.

Post your comment

In accordance with the provisions of the General Data Protection Regulation (REGULATION (EU) 2016/679), the following information about the processing of personal data is disclosed to you.

Responsible: Institut Català de la Retina, S.L., Institut Català de Cirurgia refractiva, S.L. (from now on ICR)

Representative of Data Protection Contact: C/Pau Alcover nº 67 08017 Barcelona – rgpd@icrcat.com

Aim: The purpose of the treatment is to manage the information you provide us and after having your consent, publish the testimonial on our website.

Legitimization: The legal basis for the present treatment is the request made by you and having your consent.

Recipients: The recipients of the information are the departments and delegations in which ICR is organized, in part or in its entirety. It will not be communicated to third parties.

Rights: At any time, you can exercise your rights of access, rectification, deletion, opposition, limitation of treatment and / or portability of data by writing to the RPD Representative of Data Protection at the address provided in contact. You can also revoke consents to other treatments. You can also request more information from the RPD about the treatments performed.
In the event that you consider that your rights have been violated, you can submit a claim to the competent Data Protection Control Authority.

For all purposes, the user accepts that the opinion expressed will be exclusively his /her responsibility. The user assumes under his / her exclusive responsibility the damages or harms that may derive from it.
ICR will not be responsible for the accuracy, quality, reliability, correctness, morality and legality of the data, information or opinions published by users.
ICR reserves the right not to publish all opinions of users.
The user is solely responsible of his /her username. ICR will not be responsible for the illegal use or for illicit purposes that other users can make of this user name.

Preservation: The collected data will be kept during the time required for the requested management, for at most 30 days.

ICR Ganduxer Headquarters

c/Ganduxer,117
08022 Barcelona

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona

ICR Terrassa

C. del Nord, 77
08221 Terrassa

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona
This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.